Breanne Maloney

发表

Utility of a very high IRT/No mutation referral category in cystic fibrosis newborn screening

Norma P. Tavakoli, M. Caggana, D. Kay, 2015, Pediatric pulmonology.

Creatine kinase‐MM concentration in dried blood spots from newborns and implications for newborn screening for Duchenne muscular dystrophy

Norma P. Tavakoli, M. Caggana, Sunju Park, 2022, Muscle & nerve.

Screening for cystic fibrosis in New York State: considerations for algorithm improvements

Norma P. Tavakoli, M. Caggana, D. Kay, 2016, European Journal of Pediatrics.

Newborn screening for congenital adrenal hyperplasia in New York State

Norma P. Tavakoli, M. Caggana, M. Pearce, 2016, Molecular genetics and metabolism reports.

Clinical Sensitivity of Cystic Fibrosis Mutation Panels in a Diverse Population

P. Roey, Norma P. Tavakoli, C. Stevens, 2016, Human mutation.

Newborn screening for Duchenne muscular dystrophy: A two‐year pilot study

J. Wynn, D. Tegay, B. Weinberger, 2023, Annals of clinical and translational neurology.

Utility of a very high IRT/No mutation referral category in cystic fibrosis newborn screening

Norma P. Tavakoli, M. Caggana, Jack K. Sharp, 2015, Pediatric pulmonology.

Improving Recruitment for a Newborn Screening Pilot Study with Adaptations in Response to the COVID-19 Pandemic

J. Wynn, D. Tegay, Norma P. Tavakoli, 2022, International journal of neonatal screening.

Factors Influencing Creatine Kinase-MM Concentrations in Newborns and Implications for Newborn Screening for Duchenne Muscular Dystrophy.

R. Moslehi, Norma P. Tavakoli, Wendy K. Chung, 2023, Clinical Biochemistry.